propranolol has been researched along with Intestinal Lymphangiectasis in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casero González, MM | 1 |
| Fernández Martínez, T | 1 |
| Márquez Armenteros, AM | 1 |
| Romero Albillos, A | 1 |
1 other study available for propranolol and Intestinal Lymphangiectasis
| Article | Year |
|---|---|
[Primary intestinal lymphangiectasia: Could propranolol be an effective alternative treatment?]
Topics: Adrenergic beta-Antagonists; Humans; Infant; Lymphangiectasis, Intestinal; Propranolol | 2019 |